Inhibitor | Ruxolitinib  

Compound name Brutto MW CAS PubChem CID Action Reference Reference
Ruxolitinib   C17H18N6 306.37 941678-49-5 25126798 JAKs Lawrence J Wilson (2010) Expert Opinion on Therapeutic Patents May 20(5) 609-6…

Screening Results Chart

Screening Results Tables

Screen Conc: 0.10µM
Kinase % Activity Remaining Standard Deviation
ABL 100 5
AMPK 107 6
ASK1 107 3
Aurora A 95 15
Aurora B 112 10
BRK 101 4
BRSK1 96 2
BRSK2 93 3
BTK 76 12
CAMK1 91 10
CAMKK beta 116 4
CDK2-Cyclin A 96 11
CHK1 99 0
CHK2 97 10
CK1 delta 94 11
CK2 99 1
CLK2 73 2
CSK 75 3
DAPK1 78 7
DYRK1A 101 3
DYRK2 102 15
DYRK3 97 1
EF2K 82 15
EIF2AK3 89 2
EPH-A2 107 6
EPH-A4 85 4
EPH-B1 71 2
EPH-B2 118 14
EPH-B3 96 9
EPH-B4 78 9
ERK1 97 13
ERK2 115 15
ERK8 113 5
FGF-R1 79 9
GCK 86 9
GSK3 beta 100 8
HER4 106 6
HIPK1 102 4
HIPK2 94 3
HIPK3 116 3
IGF-1R 94 11
IKK beta 96 10
IKK epsilon 93 4
IR 95 9
IRAK1 63 12
IRAK4 92 4
IRR 88 6
JAK2
3
1
JNK1 84 3
JNK2 95 8
JNK3 110 3
Lck 95 1
LKB1 95 8
MAPKAP-K2 102 13
MAPKAP-K3 89 1
MARK1 96 7
MARK2 97 6
MARK3 83 1
MARK4 94 20
MEKK1 90 8
MELK 81 11
MINK1 91 4
MKK1 108 10
MKK2 99 4
MKK6 95 5
MLK1 82 13
MLK3 90 1
MNK1 81 9
MNK2 88 11
MPSK1 104 4
MSK1 84 0
MST2 97 28
MST4 100 15
NEK2a 108 22
NEK6 88 4
NUAK1 87 10
OSR1 95 2
p38 alpha MAPK 85 15
p38 beta MAPK 101 13
p38 delta MAPK 90 14
p38 gamma MAPK 94 15
PAK2 93 4
PAK4 96 3
PAK5 94 15
PAK6 96 10
PDK1 89 6
PHK 60 3
PIM1 104 1
PIM2 87 5
PIM3 90 13
PKA 95 11
PKB alpha 102 12
PKB beta 86 15
PKC alpha 88 14
PKC gamma 93 8
PKC zeta 99 3
PKD1 101 6
PLK1 108 1
PRAK 83 16
PRK2 84 5
RIPK2 88 1
ROCK 2 60 9
RSK1 82 6
RSK2 92 4
S6K1 91 16
SGK1 100 13
SmMLCK 101 3
Src 67 14
SRPK1 85 13
STK33 108 1
SYK 96 18
TAK1 85 2
TAO1 104 1
TBK1 88 1
TIE2 98 4
TLK1 82 3
TrkA 32 1
TTK 95 7
VEGFR1 85 14
YES1 75 10
ZAP70 95 7
Screen Conc: 1.00µM
Kinase % Activity Remaining Standard Deviation
ABL 101 2
AMPK 89 10
ASK1 77 8
Aurora A 26 0
Aurora B 95 7
BRK 84 11
BRSK1 96 0
BRSK2 92 3
BTK 58 2
CAMK1 58 0
CAMKK beta 104 2
CDK2-Cyclin A 57 6
CHK1 106 7
CHK2 65 14
CK1 delta 74 6
CK2 77 6
CLK2 21 2
CSK 63 6
DAPK1 32 2
DYRK1A 67 1
DYRK2 86 12
DYRK3 107 3
EF2K 83 12
EIF2AK3 94 2
EPH-A2 62 1
EPH-A4 58 5
EPH-B1 48 4
EPH-B2 79 7
EPH-B3 86 9
EPH-B4 59 0
ERK1 111 5
ERK2 102 3
ERK8 100 8
FGF-R1 34 4
GCK 44 2
GSK3 beta 62 4
HER4 90 5
HIPK1 95 6
HIPK2 69 2
HIPK3 114 7
IGF-1R 100 5
IKK beta 105 3
IKK epsilon 73 8
IR 89 1
IRAK1 19 4
IRAK4 85 4
IRR 97 9
JAK2
2
1
JNK1 95 11
JNK2 89 13
JNK3 94 1
Lck 69 8
LKB1 83 8
MAPKAP-K2 102 9
MAPKAP-K3 101 2
MARK1 55 3
MARK2 42 7
MARK3 13 6
MARK4 88 1
MEKK1 89 6
MELK 42 7
MINK1 94 5
MKK1 73 6
MKK2 93 4
MKK6 101 8
MLK1 34 2
MLK3 46 10
MNK1 66 5
MNK2 39 1
MPSK1 101 5
MSK1 29 1
MST2 68 8
MST4 105 5
NEK2a 82 1
NEK6 92 1
NUAK1 26 1
OSR1 74 1
p38 alpha MAPK 83 1
p38 beta MAPK 102 16
p38 delta MAPK 66 3
p38 gamma MAPK 86 5
PAK2 99 2
PAK4 57 0
PAK5 72 4
PAK6 70 1
PDK1 66 8
PHK 15 0
PIM1 112 11
PIM2 90 12
PIM3 85 10
PKA 53 2
PKB alpha 77 15
PKB beta 87 4
PKC alpha 67 5
PKC gamma 80 2
PKC zeta 95 1
PKD1 83 0
PLK1 95 6
PRAK 84 3
PRK2 61 7
RIPK2 83 4
ROCK 2 36 4
RSK1 68 9
RSK2 81 3
S6K1 78 1
SGK1 75 10
SmMLCK 75 7
Src 62 4
SRPK1 67 4
STK33 84 7
SYK 83 30
TAK1 60 1
TAO1 85 15
TBK1 73 0
TIE2 78 3
TLK1 80 8
TrkA 18 3
TTK 44 2
VEGFR1 74 8
YES1 59 5
ZAP70 92 16